Publications

Show 1 to 10 of 39 results

Footer

Operated by

University of Münster
Division 6.4: Research Information Management
Department 6: Research Affairs
Domplatz 6-7 | 48143 Münster
cris@uni-muenster.de

Top-Links

About the University of Münster
Research profile of the University of Münster
CRIS-Login

living.knowledge

Legal Disclosure | Privacy Statement | Accessibility

Altvater, Bianca

Show 1 to 10 of 39 results

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma Fuest, Sebastian; Post, Christoph; Balbach, Sebastian T.; Jabar, Susanne; Neumann, Ilka; Schimmelpfennig, Sandra; Sargin, Sarah; Nass, Elke; Budde, Thomas; Kailayangiri, Sareetha; Altvater, Bianca; Ranft, Andreas; Hartmann, Wolfgang; Dirksen, Uta; Rossig, Claudia; Schwab, Albrecht; Pethő, Zoltán (2022) In: Cancers, 14(19), 4819. doi:10.3390/cancers14194819 Research article (journal) \| Peer reviewed \| Published
Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019. doi:10.15252/emmm.201809889 Research article (journal) \| Peer reviewed \| Published
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019. doi:10.1158/1078-0432.CCR-17-3553 Research article (journal) \| Peer reviewed \| Published
Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019) In: Molecular Cancer Therapeutics, 2019. doi:10.1158/1535-7163.MCT-18-0763 Research article (journal) \| Peer reviewed \| Published
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C (2017) In: OncoImmunology, 6(1). doi:10.1080/2162402X.2016.1250050 Research article (journal) \| Peer reviewed \| Published
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2), 317-320. doi:10.1038/bmt.2016.274 \| Peer reviewed
FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma In: , -. \| Peer reviewed
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies. In: . \| Peer reviewed
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation In: , -. \| Peer reviewed
Insulin-like growth factor-1 receptor (IGF-1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. In: , -. \| Peer reviewed

Research article (journal)

| Published

Trautmann M., Menzel J., Bertling C., Cyra M., Isfort I., Steinestel K., Elges S., Grünewald I., Altvater B., Rossig C., Fröhling S., Hafner S., Simmet T., Åman P., Wardelmann E., Huss S., Hartmann W.

(2017)

Clinical Cancer Research

, 23

(20)

6227

6239

doi:10.1158/1078-0432.CCR-17-0130

Research article (journal)

| Published

Roellecke K, Virts EL, Einholz R, Edson KZ, Altvater B, Rossig C, von Laer D, Scheckenbach K, Wagenmann M, Reinhardt D, Kramm CM, Rettie AE, Wiek C, Hanenberg H

(2016)

Gene Therapy

, 23

(7)

doi:10.1038/gt.2016.38

Research article (journal)

| Published

Schliemann C, Gutbrodt KL, Kerkhoff A, Pohlen M, Wiebe S, Silling G, Angenendt L, Kessler T, Mesters RM, Giovannoni L, Schäfers M, Altvater B, Rossig C, Grünewald I, Wardelmann E, Köhler G, Neri D, Stelljes M, Berdel WE

(2015)

Cancer immunology research

, 3

(5)

547

556

doi:10.1158/2326-6066.CIR-14-0179

Research article (journal)

| Published

Jamitzky S., Krueger A. C., Janneschütz S., Piepke S., Kailayangiri S., Spurny C., Rossig C., Altvater B.

(2015)

((Bitte Journal prüfen))

, 62

(11)

1979

1985

doi:10.1002/pbc.25619

Research article (journal)

| Published

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma Fuest, Sebastian; Post, Christoph; Balbach, Sebastian T.; Jabar, Susanne; Neumann, Ilka; Schimmelpfennig, Sandra; Sargin, Sarah; Nass, Elke; Budde, Thomas; Kailayangiri, Sareetha; Altvater, Bianca; Ranft, Andreas; Hartmann, Wolfgang; Dirksen, Uta; Rossig, Claudia; Schwab, Albrecht; Pethő, Zoltán (2022) In: Cancers, 14(19), 4819. doi:10.3390/cancers14194819 Research article (journal) \| Peer reviewed \| Published
Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019. doi:10.15252/emmm.201809889 Research article (journal) \| Peer reviewed \| Published
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019. doi:10.1158/1078-0432.CCR-17-3553 Research article (journal) \| Peer reviewed \| Published
Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019) In: Molecular Cancer Therapeutics, 2019. doi:10.1158/1535-7163.MCT-18-0763 Research article (journal) \| Peer reviewed \| Published
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C (2017) In: OncoImmunology, 6(1). doi:10.1080/2162402X.2016.1250050 Research article (journal) \| Peer reviewed \| Published
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2), 317-320. doi:10.1038/bmt.2016.274 \| Peer reviewed
FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma In: , -. \| Peer reviewed
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies. In: . \| Peer reviewed
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation In: , -. \| Peer reviewed
Insulin-like growth factor-1 receptor (IGF-1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. In: , -. \| Peer reviewed